Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1.
In an earlier study, levels of the proinflammatory cytokines TNF-alpha and IL-6 are higher in blisters fluid from the complex regional pain syndrome type 1 (CRPS1) side obtained at 6 and 30 months (median) after the initial event. The aim of this follow-up study is to determine the involvement of these cytokines in long lasting CRPS1. Twelve CRPS1 patients, with median disease duration of 72 months, participated. The levels of TNF-alpha and IL-6 were measured in blister fluid; disease activity was reevaluated by measuring pain and differences in temperature, volume, and mobility between both extremities. Differences in levels of IL-6 and TNF-alpha and mobility between both sides were significantly decreased. Pain and differences in temperature and volume were not significantly altered. No correlation was found between the cytokines and the disease characteristics. These results indicate that IL-6 and TNF-alpha are only partially responsible for the signs and symptoms of CRPS1.
Wesseldijk
Feikje
F
Department of Anesthesiology, Pain Treatment Center, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. f.wesseldijk@erasmusmc.nl
Huygen
Frank J P M
FJ
Heijmans-Antonissen
Claudia
C
Niehof
Sjoerd P
SP
Zijlstra
Freek J
FJ
D020918:Complex Regional Pain Syndromes / Q000378:metabolism* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha